Novo Nordisk
NVO
NVO
802 hedge funds and large institutions have $12.7B invested in Novo Nordisk in 2021 Q3 according to their latest regulatory filings, with 103 funds opening new positions, 282 increasing their positions, 233 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
15% more capital invested
Capital invested by funds: $11B → $12.7B (+$1.68B)
9% more funds holding
Funds holding: 734 → 802 (+68)
0.07% more ownership
Funds ownership: 14.85% → 14.91% (+0.07%)
Holders
802
Holding in Top 10
13
Calls
$123M
Puts
$41.6M
Top Buyers
| 1 | +$74.6M | |
| 2 | +$53.3M | |
| 3 | +$37.9M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$37.2M |
| 5 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$33.5M |
Top Sellers
| 1 | -$244M | |
| 2 | -$52.3M | |
| 3 | -$38.7M | |
| 4 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
-$21.8M |
| 5 |
CBT
Capital Bank & Trust
Irvine,
California
|
-$17.3M |